IPSEN – Buy-back programme – Art 5 of MAR – Week 24 – 2023
- 20 June 2023 - 1 mins read
Aggregated presentation by day and by market
| Name of issuer | Identification code of issuer (Legal Entity Identifier) | Day of transaction | Identification code of financial instrument | Aggregated daily volume (in number of shares) | Daily weighted average price of the purchased shares * | Market (MIC Code) |
| IPSEN | 549300M6SGDPB4Z94P11 | 12/06/2023 | FR0010259150 | 260 | 111.72 | AQEU |
| IPSEN | 549300M6SGDPB4Z94P11 | 12/06/2023 | FR0010259150 | 960 | 111.40 | CEUX |
| IPSEN | 549300M6SGDPB4Z94P11 | 12/06/2023 | FR0010259150 | 588 | 111.57 | TQEX |
| IPSEN | 549300M6SGDPB4Z94P11 | 12/06/2023 | FR0010259150 | 2,892 | 111.57 | XPAR |
| IPSEN | 549300M6SGDPB4Z94P11 | 13/06/2023 | FR0010259150 | 808 | 111.08 | AQEU |
| IPSEN | 549300M6SGDPB4Z94P11 | 13/06/2023 | FR0010259150 | 1,143 | 111.13 | CEUX |
| IPSEN | 549300M6SGDPB4Z94P11 | 13/06/2023 | FR0010259150 | 669 | 111.22 | TQEX |
| IPSEN | 549300M6SGDPB4Z94P11 | 13/06/2023 | FR0010259150 | 3,430 | 111.15 | XPAR |
| IPSEN | 549300M6SGDPB4Z94P11 | 14/06/2023 | FR0010259150 | 659 | 111.15 | AQEU |
| IPSEN | 549300M6SGDPB4Z94P11 | 14/06/2023 | FR0010259150 | 1,148 | 111.04 | CEUX |
| IPSEN | 549300M6SGDPB4Z94P11 | 14/06/2023 | FR0010259150 | 398 | 111.14 | TQEX |
| IPSEN | 549300M6SGDPB4Z94P11 | 14/06/2023 | FR0010259150 | 4,195 | 111.03 | XPAR |
| IPSEN | 549300M6SGDPB4Z94P11 | 15/06/2023 | FR0010259150 | 1,034 | 110.72 | AQEU |
| IPSEN | 549300M6SGDPB4Z94P11 | 15/06/2023 | FR0010259150 | 1,504 | 110.67 | CEUX |
| IPSEN | 549300M6SGDPB4Z94P11 | 15/06/2023 | FR0010259150 | 584 | 110.65 | TQEX |
| IPSEN | 549300M6SGDPB4Z94P11 | 15/06/2023 | FR0010259150 | 4,678 | 110.57 | XPAR |
| IPSEN | 549300M6SGDPB4Z94P11 | 16/06/2023 | FR0010259150 | 210 | 111.17 | AQEU |
| IPSEN | 549300M6SGDPB4Z94P11 | 16/06/2023 | FR0010259150 | 387 | 111.89 | CEUX |
| IPSEN | 549300M6SGDPB4Z94P11 | 16/06/2023 | FR0010259150 | 223 | 112.19 | TQEX |
| IPSEN | 549300M6SGDPB4Z94P11 | 16/06/2023 | FR0010259150 | 1,947 | 112.10 | XPAR |
| * Two-digit rounding after the decimal | TOTAL | 27,717 | 111.13 | |||
Attachment
07 May 2024
5 mins read
Ipsen S.A. – Formalities for making available and consulting preparatory documents to the 2024 Annual General Meeting
06 May 2024
1 mins read
Ipsen – Monthly information relative to the total number of voting rights and shares composing the share capital
24 April 2024
7 mins read
Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance
22 April 2024
5 mins read
Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseases
17 April 2024
4 mins read
Ipsen publishes its 2023 Universal Registration Document
08 April 2024
1 mins read
Ipsen – Monthly information relative to the total number of voting rights and shares composing the share capital
02 April 2024
7 mins read
Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumors
07 March 2024
1 mins read
Ipsen – Monthly information relative to the total number of voting rights and shares composing the share capital
15 February 2024
1 mins read
Ipsen S.A. publishes its 2023 Consolidated Financial Statements
13 February 2024
14 mins read